Neumora Therapeutics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Results of Operations and Financial Condition

Other Events

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Other Events

Unregistered Sales of Equity Securities

Results of Operations and Financial Condition

Other Events

Other Events

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Post-effective amendment to a registration statement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Automatic Shelf Registration

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

06b

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

BERNS PAUL L

Duncan Jason

Milligan Michael Lee

Pinto Joshua

Aurora Daljit Singh

Aurora Daljit Singh

Aurora Daljit Singh

Aurora Daljit Singh

Aurora Daljit Singh

Aurora Daljit Singh

Aurora Daljit Singh

Burow Kristina

Piacquad David

Halawa Alaa

Ho Maykin

Fust Matthew K

K2 HealthVentures Equity Trust LLC

Invus Global Management, LLC

ARCH Venture Fund XII, L.P.

Milligan Michael Lee

Post-effective amendment to an automatic shelf registration statement

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

No description available

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC